FDA INTERIM RULE TARGETS BSE IN COSMETICS & OTHER PRODUCTS

A July 9 Food and Drug Administration (FDA) interim rule on bovine spongiform encephalopathy (BSE) in cosmetics, cosmetics ingredients, foods and dietary supplements forbids use of cattle material such as ... Log in to view full article.

Already a subscriber?

Email: REQUIRED

Password: REQUIRED

Forgot your password? Click here to have your password emailed to you.

NOT YET A MEMBER?

Purchase a Membership
with a money-back guarantee
and immediate access